Sign Up to like & get
recommendations!
1
Published in 2017 at "European Psychiatry"
DOI: 10.1016/j.eurpsy.2017.01.378
Abstract: Introduction Several studies have shown that ketamine, an antagonist of NMDA receptors, represents a promising alternative in the treatment of depression. The therapeutic use of ketamine, commonly used at a dose of 0.5 mg/kg, and…
read more here.
Keywords:
depression;
ketamine;
case;
intramuscular ketamine ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "International Review of Psychiatry"
DOI: 10.1080/09540261.2020.1854194
Abstract: Abstract Over the last two decades, the dissociative anaesthetic agent ketamine, an uncompetitive N-Methyl-D-Aspartate (NMDA) receptor antagonist, has emerged as a novel therapy for treatment-resistant depression (TRD), demonstrating rapid and robust antidepressant effects within hours…
read more here.
Keywords:
depression;
treatment;
ketamine;
pharmacology ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International clinical psychopharmacology"
DOI: 10.1097/yic.0000000000000462
Abstract: Medical Aid in Dying (MAiD) is the act of a healthcare provider ending a patient's life, at their request, due to unbearable suffering from a grievous and incurable disease. Access to MAiD has expanded in…
read more here.
Keywords:
aid dying;
ketamine depression;
depression potential;
depression ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Pharmaceuticals"
DOI: 10.3390/ph13070151
Abstract: The objective of this study was to investigate the safety of repeated parenteral ketamine for depression. An electronic survey inquiring about the frequency of adverse events was distributed to providers of parenteral ketamine for depression.…
read more here.
Keywords:
depression;
parenteral ketamine;
safety repeated;
ketamine depression ... See more keywords